Moreover, m6A modification and YTHDF2 enrichment on TUG1 were reduced in AML cells, and further diminished in drug-resistant cells (P < 0.01, Figure 3C), while silencing ALKBH5 enhanced both (P < 0.01, Figure 3C). The gene discussed is ALKBH5; the disease is acute myeloid leukemia.